NCT02860507View on ClinicalTrials.gov

Study to Determine if Administration of Sugammadex Impacts Hospital Efficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Neuromuscular Blockade
Interventions
DRUG

sugammadex

DRUG

Neostigmine

DRUG

Glycopyrrolate

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of South Florida

OTHER

NCT02860507 - Study to Determine if Administration of Sugammadex Impacts Hospital Efficiency | Biotech Hunter | Biotech Hunter